Study of Rapamycin Plus Ketoconazole in Advanced Cancers

NCT00708591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Rapamycin
DRUG: Ketoconazole

Sponsor

University of Chicago